|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Comparison of highly purified FSH (metrodin-high purity) with pergonal for IVF superovulation显示文摘 | Lockwood G Lopez BA | 1998 | J Assist Reprod Genet1998，15，2： | 1 |
| 2 | 2004 WHO classifi- cation of the renal tumors of the adults 显示文摘 | Lopez BA Scarpelli M Montironi R | 2006 | Eum Urol2006，49，5： | 1 |
| 3 | First Highly Efficient and Photostable E and C Derivatives of 4,4‐Difluoro‐4‐bora‐3a,4a‐diaza‐ s ‐indacene (BODIPY) as Dye Lasers in the Liquid Phase, Thin Films, and Solid‐State Rods显示文摘 | Gonzalo Duran‐Sampedro Ixone Esnal Antonia R. Agarrabeitia Jorge Ba?uelos Prieto Luis Cerdán Inmaculada García‐Moreno Angel Costela I?igo Lopez‐Arbeloa María J. Ortiz | 2014 | Chem. Eur. J2014，，9： | 1 |
| 4 | Antiphospholipid antibodies are related to portal vein thrombosis in patients with liver cirrhosis 显示文摘 | ROMERO GOMEZ M SU/REZGARCiA E LOPEZ LACOM- BA D | 2000 | J Clin Gastroenterol2000，31，： | 1 |
| 5 | The Streptococcus gordonii surface proteins GspB and Hsa mediate binding to sialylated carbohydrate epitopes on the platelet membrane glycoprotein Iba 显示文摘 | Bensing BA Lopez JA Sullam PM | 2004 | Infect Immun2004，72，11： | 1 |
| 6 | An open source approach to creating positive psychological practice:A comment on Wong' s Strengths-centered Therapy显示文摘 | Lopez SJ Kerr BA | 2006 | Psychother Theory Res Pract Train2006，43，2： | 1 |
| 7 | An open source approach to creating positive psychological practice:A comment on Wong 's Strengths-centered Therapy显示文摘 | Lopez SJ Kerr BA | 2006 | Psychother Theory Res Pract Train2006，43，2： | 1 |
| 8 | Early membrane damage during coronary reperfusion in dogs: detection by radiolabelled anticardiac myos in (Fab')2显示文摘 | Lopez JA Khaw BA | 1983 | J Clin1983，72，： | 1 |
| 9 | Altered metabolic and adhesive properties and increased tumorigenisis associated with incrased expression of transforming growth factor beta显示文摘 | Lopez AR Elfman F | 1992 | J cell Biol1992，118，3： | 1 |
| 10 | Telemedicine, Telehealth, and Mobile Health Applications That Work: Opportunities and Barriers 显示文摘 | Weinstein RS Lopez AM Joseph BA | 2014 | Am J Med2014，127，： | 1 |
| 11 | Cross-talk between iron metabolism and diabetes显示文摘 | Fernandez RJM Lopez BA Ricart W | 2002 | Diabetes2002，51，8： | 1 |
| 12 | Novel interactions of adiponectin with the endocrine system and inflammatory parameters显示文摘 | Fernandez RJM Lopez BA Casamitjana R | 2003 | J Clin Endocrinol Metab2003，88，6： | 1 |
| 13 | Separation of phospholipid classes in sea urchin, paracentrotus lividus by high-performance liquid chromatography显示文摘 | Rodriguez BA Lopez HJ Simal LJ | 2002 | J Chromatogr B2002，770，1： | 1 |
| 14 | Hepatocellular carcinoma risk after viral response in hepatitis C virus-advanced fibrosis: Who to screen and for how long?显示文摘Hepatitis C virus(HCV)chronic infection is associated with fibrosis progression,end-stage liver complications and HCC.Not surprisingly,HCV infection is a leading cause of liver-related morbidity and mortality worldwide.After sustained virological response(SVR),the risk of developing hepatocellular carcinoma is not completely eliminated in patients with established cirrhosis or with advanced fibrosis.Therefore,lifelong surveillance is currently recommended.This strategy is likely not universally cost-effective and harmless,considering that not all patients with advanced fibrosis have the same risk of developing HCC.Factors related to the severity of liver disease and its potential to improve after SVR,the molecular and epigenetic changes that occur during infection and other associated comorbidities might account for different risk levels and are likely essential for identifying patients who would benefit from screening programs after SVR.Efforts to develop predictive models and risk calculators,biomarkers and genetic panels and even deep learning models to estimate the individual risk of HCC have been made in the direct-acting antiviral agents era,when thousands of patients with advanced fibrosis and cirrhosis have reached SVR.These tools could help to identify patients with very low HCC risk in whom surveillance might not be justified.In this review,factors affecting the probability of HCC development after SVR,the benefits and risks of surveillance,suggested strategies to estimate individualized HCC risk and the current evidence to recommend lifelong surveillance are discussed. | Adriana Ahumada Laura Rayón Clara Usón Rafael Bañares Sonia Alonso Lopez | 2021 | World Journal of Gastroenterology2021，27，40： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员